Conferences talk.
Forums shape outcomes.

Days

Hours

Minutes

Seconds

Learn More & Register

Rewind to ACCESS US '26 NOLA!

Clark Paramore, Head of Global Value Evidence Strategy at Biogen, reflects on a standout event — from timely conversations on MFN and JCA to high-caliber speakers and the invaluable networking opportunities that brought together industry professionals and manufacturers. Watch to hear why events like this matter.

At ACCESS Forum New Orleans 2025, Sarah Emond, President and CEO, Institute for Clinical and Economic Review (ICER), shares why the ACCESS Forum is such a valuable experience: the opportunity to engage with great experts, hear the latest news, and foster meaningful dialogue between companies. She reflects on the rich conversations with fellow manufacturers and the chance to walk away with a wealth of new information — making it a meeting she truly enjoys. Watch to hear why events like this matter.

Download the VISION

ACCESS US '25: Austin

Thanks for joining us!

See Highlights

Our Podcast Partner:
Prescription for Better Access

Episode 35:

A Legal Perpective on

PBM Reform and

FTC Enforcement

Listen

Hot Topics

Extra! Extra!

Hot Takes from ACCESS US '26 NOLA—#1

CMS plenary: Inman Hernandez on drug pricing

Executive highlight summary
This plenary made clear that U.S. drug pricing is no longer a domestic policy issue alone. MFN-linked policy, Medicare demonstrations, GLP-1 coverage expansion, and international pricing spillovers are becoming part of one interconnected access environment. The most important takeaway for executives is that pricing, access, trade policy, and public affordability optics are now moving together. Leaders can no longer afford to manage these as separate workstreams.

Download for More

Introducing The Access Forum Executive Brief

In the past few years, we’ve witnessed unprecedented policy and pricing reforms. Today they are creating seismic shifts for global market access. Decisions once treated as local or tactical now carry current and future global cross-portfolio consequences.

Read the X-Brief Vol. 1

Executive Brief Volume 2

Net Price Governance Net price decisions made today determine 2026–2028 portfolio value. Organizations that govern net price proactively will protect launch integrity, preserve margin, and stabilize enterprise value.

Read the X-Brief Vol. 2

From the Innovation Incubator

Empowering Medicare Recipients to Increase Program Efficiencies:
A People First Plan
by Anuja Roy and Kome Okposo

Conferences talk.Forums shape outcomes.

Conferences talk.
Forums shape outcomes.